Authors
Loading...
May enable scalable oral norovirus vaccines; leaves open human immunogenicity and efficacy.
Key points are not available for this paper at this time.
Xia et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: